BioStone Animal Health Acquires American Animal Health Assets, Expands USDA-Licensed Autogenous Bacterin Manufacturing Capabilities

News

Southlake, TX / Grand Prairie, TX — February 23, 2026  — BioStone Animal Health announced today that it has acquired the business assets of American Animal Health, Inc. (AAH), including AAH’s USDA-licensed manufacturing facility in Grand Prairie, Texas (Est. 315). The acquisition strengthens BioStone’s ability to serve veterinarians and producers with high-quality, herd-specific autogenous bacterins supported by established manufacturing…

BioStone Animal Health Advances Nipah Virus Antibody Surveillance with Multi-Species iELISA

News

DALLAS-FORT WORTH, TX — January 29, 2026  — In response to the recent Nipah virus (NiV) outbreak reported in India, BioStone Animal Health has launched a multi-species indirect ELISA (iELISA) Test kit for Nipah virus antibody detection (Cat. 10101), designed to support surveillance, biosecurity, and outbreak preparedness. Nipah virus is a highly pathogenic zoonotic virus with recurrent outbreaks…

BioStone Animal Health Launches CL (Caseous Lymphadenitis, Corynebacterium pseudotuberculosis) Antibody ELISA Test Kit

News

DALLAS-FORT WORTH, TX— January 26, 2026 — BioStone Animal Health is pleased to announce the launch of the AsurDx™ Caseous Lymphadenitis (Corynebacterium pseudotuberculosis) Antibody ELISA Test Kit, designed for the detection of antibodies specific to Corynebacterium pseudotuberculosis in goat and sheep serum or plasma samples. About AsurDx™ CL Antibody ELISA Test Kit The AsurDx™ Caseous Lymphadenitis Antibody…